At the news
? NEUTRALIMPACT 3/10 S-3 filed Nov 13, 2026 at 16:04 ET
Lyell Immunopharma filed an S-3 registration statement to register 7,428,040 shares of common stock for resale by selling stockholders who acquired them in a private placement that closed on November 4, 2026 at $10.77 per share. The company will not receive any proceeds from the resale; the filing is a contractual obligation under the securities purchase agreement. The private placement raised $80M (stated in the prior earnings report) and extends the company's cash runway into 2028.
- S-3 registers 7,428,040 shares of common stock for resale by selling stockholders
- Shares were issued at $10.77 per share in a private placement that closed November 4, 2026
- Company will not receive any proceeds from the resale
- Maximum aggregate offering price calculated at $114,540,376.80 based on $15.42 reference price
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access